The 20 Best Hormone Replacement Therapy (HRT) Doctors Near Me

Ranjith Ramasamy is a Urologist in Coral Gables, Florida. Dr. Ramasamy is rated as an Elite provider by MediFind in Hormone Replacement Therapy (HRT). His top areas of expertise are Testicular Failure, Hypogonadism, Erectile Dysfunction (ED), Vasectomy, and Hormone Replacement Therapy (HRT).

Ashraf Soliman practices in Doha, Qatar. Mr. Soliman is rated as an Elite expert by MediFind in Hormone Replacement Therapy (HRT). His top areas of expertise are Beta Thalassemia, Thalassemia, Congenital Hemolytic Anemia, Hormone Replacement Therapy (HRT), and Splenectomy.

Andrea Gropman is a Pediatrics provider in Washington, Washington, D.c.. Dr. Gropman is rated as an Elite provider by MediFind in Hormone Replacement Therapy (HRT). Her top areas of expertise are Klinefelter Syndrome, Urea Cycle Disorders (UCD), Ornithine Transcarbamylase Deficiency, MELAS Syndrome, and Hormone Replacement Therapy (HRT).

Michael Zitzmann practices in Muenster, Germany. Mr. Zitzmann is rated as an Elite expert by MediFind in Hormone Replacement Therapy (HRT). His top areas of expertise are Hypogonadism, Klinefelter Syndrome, Hypogonadotropic Hypogonadism, Hormone Replacement Therapy (HRT), and Orchiectomy.

Norio Nonomura practices in Suita, Japan. Mr. Nonomura is rated as an Elite expert by MediFind in Hormone Replacement Therapy (HRT). His top areas of expertise are Renal Cell Carcinoma (RCC), Urothelial Cancer, Prostate Cancer, Kidney Transplant, and Nephrectomy.

Han-wook Yoo practices in Seoul, Republic of Korea. Yoo is rated as an Elite expert by MediFind in Hormone Replacement Therapy (HRT). Their top areas of expertise are Congenital Lipoid Adrenal Hyperplasia, Idiopathic Short Stature (ISS), Citrullinemia, Hormone Replacement Therapy (HRT), and Liver Transplant.

Shigeo Horie practices in Hongo, Japan. Mr. Horie is rated as an Elite expert by MediFind in Hormone Replacement Therapy (HRT). His top areas of expertise are Polycystic Kidney Disease, Autosomal Dominant Polycystic Kidney Disease, Hypogonadism, Bladder Reconstruction, and Prostatectomy.

Dr. Samuel Denmeade is the R. Dale Hughes Professor of Oncology and Urology at the Johns Hopkins University School of Medicine and Director of the Genitourinary Oncology Division for the Johns Hopkins Kimmel Cancer Center. He also has appointments in the Department of Pharmacology and Molecular Sciences and Department of Biomolecular Engineering. His areas of clinical expertise include bladder cancer, kidney cancer, prostate cancer and testicular cancer. Dr. Denmeade earned his M.D. from the Columbia College of Physicians and Surgeons of Columbia University. He completed his residency at the University of Chicago. He performed a fellowship in oncology at The Johns Hopkins Hospital and a fellowship in medical oncology at the Johns Hopkins University School of Medicine. His research interests include prostate cancer, bipolar androgen therapy, clinical trials and targeted drug development. Dr. Denmeade has published over 200 papers in the area of prostate cancer research. He has received extensive funding from the NIH, the Department of Defense Prostate Cancer Research Fund and the Prostate Cancer Foundation. He is the Editor-in-Chief of the medical journal The Prostate. Dr. Denmeade is rated as a Distinguished provider by MediFind in Hormone Replacement Therapy (HRT). His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Renal Cell Carcinoma (RCC), Hormone Replacement Therapy (HRT), and Prostatectomy.

Dr. Channing J. Paller is a medical oncologist at Sibley Memorial Hospital and a professor of oncology at the Johns Hopkins University School of Medicine. She practices out of the Prostate Cancer Multidisciplinary Clinic at Sibley Memorial Hospital in Washington, D.C., and the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins in Baltimore, MD. Dr. Paller has expertise in prostate, bladder, kidney, and testicular cancer. Dr. Paller earned her medical degree from Harvard Medical School and completed a residency in internal medicine, followed by a fellowship in hematology and oncology at Johns Hopkins University School of Medicine. In addition, Dr. Paller completed a rotation with the chief of the Investigational Drug Branch at the National Cancer Institute (NCI) Cancer Therapy Evaluation Program and a rotation with the associate director for regulatory science in the Office of Oncology Drug Products at the Food and Drug Administration. She also completed rotations at the Weizmann Institute of Israel’s Department of Biological Regulation and McCord Hospital in South Africa, where she participated in the Harvard AIDS project. In 2016, Dr. Paller was one of only five oncologists awarded the NCI Mentored Patient-Oriented Research Career Development Award. In 2015, she received the 2015 Passano Clinician Scientist Award for early-stage research that is already making a contribution to science. Earlier in her career, she was selected for both a 2011-2012 Young Investigator Award by the American Society of Clinical Oncology and for the 2011-12 Eastern Cooperative Oncology Group Paul Carbone Award. Dr. Paller is a member of the American Society of Clinical Oncology and the American Association for Cancer Research. Dr. Paller’s research focuses on evaluating new therapies for prostate cancer, particularly combination therapies that engage the immune system. She is the principal investigator on two multi-site clinical trials and was the first author on the NCI Investigational Drug Steering Committee publication, “Consensus Recommendations on the Phase I Combination Clinical Trials of the Clinical Trial Design Task Force.” Dr. Paller was the chair for the oral abstract session on genitourinary cancer at the 2015 Annual Meeting of the American Society of Clinical Oncology and she is currently funded by an NCI immunotherapy grant to look at combination therapies that link standard of care therapy with inhibition of transforming growth factor beta in prostate cancer. She is also opening trials of vitamin C with chemotherapy in prostate cancer and of mistletoe in all solid tumors. Dr. Paller is rated as a Distinguished provider by MediFind in Hormone Replacement Therapy (HRT). Her top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Muscle Invasive Bladder Cancer, Hormone Replacement Therapy (HRT), and Prostatectomy.

Dr. Dobs is presently an active clinical researcher in the field of endocrine gonadal function. She is particularly interested in new forms of male hormone replacement therapy and has published extensively in the area of hormonal changes with aging and chronic disease. Her clinical practice covers general endocrinology, with a focus on sex hormone disorders in both men and women. As Director of the Johns Hopkins Clinical Research Network, she oversees a multi-institutional consortium of hospitals in the mid-Atlantic states dedicated to facilitating clinical research through an academic-community hospital partnership. Dr. Dobs is rated as a Distinguished provider by MediFind in Hormone Replacement Therapy (HRT). Her top areas of expertise are Hypogonadism, Eunuchoidism Familial Hypogonadotropic, Testicular Failure, Isolated Hypogonadotropic Hypogonadism, and Hormone Replacement Therapy (HRT).

Ronald Swerdloff is an Endocrinologist in Torrance, California. Dr. Swerdloff is rated as a Distinguished provider by MediFind in Hormone Replacement Therapy (HRT). His top areas of expertise are Hypogonadism, Isolated Hypogonadotropic Hypogonadism, Low Testosterone, Hormone Replacement Therapy (HRT), and Orchiectomy.

Randall Urban is an Endocrinologist in Galveston, Texas. Dr. Urban has been practicing medicine for over 44 years and is rated as a Distinguished provider by MediFind in Hormone Replacement Therapy (HRT). His top areas of expertise are Hypopituitarism, Sheehan Syndrome, Hypogonadism, Hormone Replacement Therapy (HRT), and Orchiectomy.

Shehzad Basaria is an Endocrinologist in Boston, Massachusetts. Dr. Basaria is rated as a Distinguished provider by MediFind in Hormone Replacement Therapy (HRT). His top areas of expertise are Low Testosterone, Isolated Hypogonadotropic Hypogonadism, Eunuchoidism Familial Hypogonadotropic, Hormone Replacement Therapy (HRT), and Orchiectomy.

Shalender Bhasin is an Endocrinologist in Boston, Massachusetts. Dr. Bhasin is rated as a Distinguished provider by MediFind in Hormone Replacement Therapy (HRT). His top areas of expertise are Hypogonadism, Isolated Hypogonadotropic Hypogonadism, Low Testosterone, Hormone Replacement Therapy (HRT), and Orchiectomy.

Alan Rogol is a Pediatric Endocrinologist in Charlottesville, Virginia. Dr. Rogol is rated as a Distinguished provider by MediFind in Hormone Replacement Therapy (HRT). His top areas of expertise are Pediatric Growth Hormone Deficiency, Hypogonadism, Growth Hormone Deficiency (GHD), Klinefelter Syndrome, and Hormone Replacement Therapy (HRT).

Molly Moravek is an Obstetrics and Gynecologist in Rochester Hills, Michigan. Dr. Moravek is rated as a Distinguished provider by MediFind in Hormone Replacement Therapy (HRT). Her top areas of expertise are Infertility, Uterine Fibroids, Premature Ovarian Failure, Hormone Replacement Therapy (HRT), and Oophorectomy.

Atsushi Mizokami practices in Kanazawa, Japan. Mr. Mizokami is rated as a Distinguished expert by MediFind in Hormone Replacement Therapy (HRT). His top areas of expertise are Prostate Cancer, Hypogonadism, Isolated Hypogonadotropic Hypogonadism, Hormone Replacement Therapy (HRT), and Prostatectomy.

Kok-yong Chin practices in Kuala Lumpur, Malaysia. Chin is rated as a Distinguished expert by MediFind in Hormone Replacement Therapy (HRT). Their top areas of expertise are Osteoporosis, Metabolic Syndrome, Abdominal Obesity Metabolic Syndrome, Orchiectomy, and Oophorectomy.

Rodolfo Rey practices in Argentina. Mr. Rey is rated as a Distinguished expert by MediFind in Hormone Replacement Therapy (HRT). His top areas of expertise are Intersex, Hypogonadism, Undescended Testicle, Hypogonadotropic Hypogonadism, and Hormone Replacement Therapy (HRT).

Robert Krysiak practices in Bytom, Poland. Mr. Krysiak is rated as a Distinguished expert by MediFind in Hormone Replacement Therapy (HRT). His top areas of expertise are Hashimoto Thyroiditis, Hypothyroidism, Ovarian Overproduction of Androgens, Autoimmune Polyglandular Syndrome Type 2, and Hormone Replacement Therapy (HRT).